Does SORAFENIB Cause Hepatic neoplasm? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Hepatic neoplasm have been filed in association with SORAFENIB (sorafenib). This represents 0.3% of all adverse event reports for SORAFENIB.
27
Reports of Hepatic neoplasm with SORAFENIB
0.3%
of all SORAFENIB reports
6
Deaths
10
Hospitalizations
How Dangerous Is Hepatic neoplasm From SORAFENIB?
Of the 27 reports, 6 (22.2%) resulted in death, 10 (37.0%) required hospitalization.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SORAFENIB. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does SORAFENIB Cause?
Hepatocellular carcinoma (1,665)
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Palmar-plantar erythrodysaesthesia syndrome (1,040)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
BEVACIZUMAB (49)
RIBAVIRIN (49)
METFORMIN (47)
Which SORAFENIB Alternatives Have Lower Hepatic neoplasm Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK